Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Han, Changsu
Yeh, Tzung Lieh
Kato, Masaki
Sato, Soichiro
Chang, Chia-Ming
and
Pae, Chi-Un
2013.
Management of Chronic Depressive Patients with Residual Symptoms.
CNS Drugs,
Vol. 27,
Issue. S1,
p.
53.
Han, Changsu
Wang, Sheng-Min
Kato, Masaki
Lee, Soo-Jung
Patkar, Ashwin A
Masand, Prakash S
and
Pae, Chi-Un
2013.
Second-generation antipsychotics in the treatment of major depressive disorder: current evidence.
Expert Review of Neurotherapeutics,
Vol. 13,
Issue. 7,
p.
851.
IsHak, Waguih William
Greenberg, Jared M.
and
Cohen, Robert M.
2013.
Predicting relapse in major depressive disorder using patient-reported outcomes of depressive symptom severity, functioning, and quality of life in the individual burden of illness index for depression (IBI-D).
Journal of Affective Disorders,
Vol. 151,
Issue. 1,
p.
59.
Pan, Y.-J.
Knapp, M.
and
McCrone, P.
2014.
Impact of initial treatment outcome on long-term costs of depression: a 3-year nationwide follow-up study in Taiwan.
Psychological Medicine,
Vol. 44,
Issue. 6,
p.
1147.
Icick, Romain
Millet, Élodie
Curis, Emmanuel
Bellivier, Frank
and
Lépine, Jean-Pierre
2014.
Predictive value of baseline resistance in early response to antidepressants.
Journal of Affective Disorders,
Vol. 161,
Issue. ,
p.
127.
Tomaz, V.S.
Cordeiro, R.C.
Costa, A.M.N.
de Lucena, D.F.
Nobre Júnior, H.V.
de Sousa, F.C.F.
Vasconcelos, S.M.M.
Vale, M.L.
Quevedo, J.
and
Macêdo, D.
2014.
Antidepressant-like effect of nitric oxide synthase inhibitors and sildenafil against lipopolysaccharide-induced depressive-like behavior in mice.
Neuroscience,
Vol. 268,
Issue. ,
p.
236.
Kogan, Steven M.
Yu, Tianyi
Allen, Kimberly A.
and
Brody, Gene H.
2015.
Racial Microstressors, Racial Self-Concept, and Depressive Symptoms Among Male African Americans During the Transition to Adulthood.
Journal of Youth and Adolescence,
Vol. 44,
Issue. 4,
p.
898.
Montgomery, Stuart A.
Gommoll, Carl P.
Chen, Changzheng
and
Greenberg, William M.
2015.
Efficacy of levomilnacipran extended-release in major depressive disorder: pooled analysis of 5 double-blind, placebo-controlled trials.
CNS Spectrums,
Vol. 20,
Issue. 2,
p.
148.
IsHak, W. W.
Mirocha, J.
James, D.
Tobia, G.
Vilhauer, J.
Fakhry, H.
Pi, S.
Hanson, E.
Nashawati, R.
Peselow, E. D.
and
Cohen, R. M.
2015.
Quality of life in major depressive disorder before/after multiple steps of treatment and one‐year follow‐up.
Acta Psychiatrica Scandinavica,
Vol. 131,
Issue. 1,
p.
51.
Myung, W
Kim, J
Lim, S-W
Shim, S
Won, H-H
Kim, Seonwoo
Kim, Sangha
Lee, M-S
Chang, H S
Kim, J-W
Carroll, B J
and
Kim, D K
2015.
A genome-wide association study of antidepressant response in Koreans.
Translational Psychiatry,
Vol. 5,
Issue. 9,
p.
e633.
Kornstein, Susan G.
Gommoll, Carl
Chen, Changzheng
and
Kramer, Kenneth
2016.
The effects of levomilnacipran ER in adult patients with first-episode, highly recurrent, or chronic MDD.
Journal of Affective Disorders,
Vol. 193,
Issue. ,
p.
137.
IsHak, Waguih William
James, David M.
Mirocha, James
Youssef, Haidy
Tobia, Gabriel
Pi, Sarah
Collison, Katherine L.
and
Cohen, Robert M.
2016.
Patient-reported functioning in major depressive disorder.
Therapeutic Advances in Chronic Disease,
Vol. 7,
Issue. 3,
p.
160.
Richards, Erica M.
Mathews, Daniel C.
Luckenbaugh, David A.
Ionescu, Dawn F.
Machado-Vieira, Rodrigo
Niciu, Mark J.
Duncan, Wallace C.
Nolan, Neal M.
Franco-Chaves, Jose A.
Hudzik, Thomas
Maciag, Carla
Li, Shuang
Cross, Alan
Smith, Mark A.
and
Zarate, Carlos A.
2016.
A randomized, placebo-controlled pilot trial of the delta opioid receptor agonist AZD2327 in anxious depression.
Psychopharmacology,
Vol. 233,
Issue. 6,
p.
1119.
Goodyer, Ian M
Reynolds, Shirley
Barrett, Barbara
Byford, Sarah
Dubicka, Bernadka
Hill, Jonathan
Holland, Fiona
Kelvin, Raphael
Midgley, Nick
Roberts, Chris
Senior, Rob
Target, Mary
Widmer, Barry
Wilkinson, Paul
and
Fonagy, Peter
2017.
Cognitive behavioural therapy and short-term psychoanalytical psychotherapy versus a brief psychosocial intervention in adolescents with unipolar major depressive disorder (IMPACT): a multicentre, pragmatic, observer-blind, randomised controlled superiority trial.
The Lancet Psychiatry,
Vol. 4,
Issue. 2,
p.
109.
Guo, Boliang
Kaylor-Hughes, Catherine
Garland, Anne
Nixon, Neil
Sweeney, Tim
Simpson, Sandra
Dalgleish, Tim
Ramana, Rajini
Yang, Min
and
Morriss, Richard
2017.
Factor structure and longitudinal measurement invariance of PHQ-9 for specialist mental health care patients with persistent major depressive disorder: Exploratory Structural Equation Modelling.
Journal of Affective Disorders,
Vol. 219,
Issue. ,
p.
1.
White, Daniel K.
Neogi, Tuhina
Zhang, Yuqing
Niu, Jingbo
and
Katz, Patricia P.
2017.
Association of Slow Gait Speed With Trajectories of Worsening Depressive Symptoms in Knee Osteoarthritis: An Observational Study.
Arthritis Care & Research,
Vol. 69,
Issue. 2,
p.
209.
Mulder, R.
Boden, J.
Carter, J.
Luty, S.
and
Joyce, P.
2017.
Ten month outcome of cognitive behavioural therapy v. interpersonal psychotherapy in patients with major depression: a randomised trial of acute and maintenance psychotherapy.
Psychological Medicine,
Vol. 47,
Issue. 14,
p.
2540.
STEINER, ALEXANDER J.
BOULOS, NATHALIE
WRIGHT, STEPHANIE M.
MIROCHA, JAMES
SMITH, KIMBERLY
LÓPEZ, ENRIQUE
GOHAR, SHERIF H.
and
ISHAK, WAGUIH W.
2017.
Major Depressive Disorder in Patients With Doctoral Degrees: Patient-reported Depressive Symptom Severity, Functioning, and Quality of Life Before and After Initial Treatment in the STAR*D Study.
Journal of Psychiatric Practice,
Vol. 23,
Issue. 5,
p.
328.
Velasquez, Daniela
Quines, Caroline
Pistóia, Renan
Zeni, Gilson
and
Nogueira, Cristina W.
2017.
Selective inhibition of MAO-A activity results in an antidepressant-like action of 2-benzoyl 4-iodoselenophene in mice.
Physiology & Behavior,
Vol. 170,
Issue. ,
p.
100.
2017.
Uexküll, Psychosomatische Medizin.
p.
1.